Please use symbol entry at top right of page to search

Emerging Markets Report: A Case for Uranium

An Emerging Markets Sponsored Commentary

ORLANDO, Fla., May 26, 2022 (GLOBE NEWSWIRE) -- There’s a funny thing about resource companies, particularly those who mine the dirt beneath their feet.

Sometimes that earth moves on its own, figuratively of course, but it moves.

This virtual movement can be good or bad. Gold buyers saw crypto siphon off investors at one point and the metal didn’t appreciate like most other assets in the recent bull market. The cost of mining gold was likely unchanged, but the spot price in the market wasn’t rising due to external, global factors.

But that door of impact swings both ways as we begin to introduce Laramide Resources Ltd. (LMRXF) , an exploration and development company, which holds diversified uranium assets strategically positioned in the United States and Australia that have been chosen for their low-cost production potential. Let’s examine for a moment the geopolitical factors through the reportage of completely unaffiliated news outlets who are in the collective, making a case for uranium, and we believe, a reason to dive deeper into a review of Laramide.

Before we do that it is necessary to establish a little pedigree for Laramide herein. You may have not noticed in the string of domestic and international ticker symbols above but Laramide is traded on the OTCQX, the highest tier of OTC Markets. The OTCQB, where most stories we cover trade, is the second tier of the markets operated by OTC Markets Group, below OTCQX and above Pink.

Now, back to Uranium.

In a report from S&P Global with the headline “Uranium buyers, Ukraine conflict drive spot price to 10-year high” yellowcake’s recent price appreciation can be directly pegged to a buying spree by financial entities, mainly Sprott, and to the war:

“Russia's invasion of Ukraine has threatened to rattle uranium supply chains and spurred a wave of investor buying in the market, pushing uranium prices above $50/lb for the first time in 10 years.”

That article was written March 11, 2022. In May, that price was even higher.

A mining publication this week wrote, “US, Canadian companies set to soar on Russian uranium ban,” based on comments by GoldSilver.com's senior precious metals analyst, Jeff Clark.

The impact has already been felt in uranium bellwether stocks like Cameco and NexGen with an industry analyst stating that those two equities “have more room to run after climbing more than 40 per cent so far in 2022.” Here’s a link to that report.

It didn’t take us long to curate compelling headlines about the current market for uranium. Bullish reports abound including this one from S&P Global Market Intelligence again with the header, “High Prices Lure Uranium Explorers to the U.S.”

We are at the very beginning of our coverage of Laramide Resources (LMRXF) which appears to be in the right industry at the right time. Located in the safe and politically stable jurisdictions of the United States and Australia, Laramide’s exploration development uranium projects include one of a handful in the world not under the control of a major mining company. Its US projects are in the historic uranium mining region of New Mexico and another in Utah very close to the only fully-licensed and operating conventional uranium mill in the United States.

We will watch how Laramide, in its exploration and development stage potentially catches the tailwinds of this uranium cycle to potentially push their projects toward production.

These turbulent, terrible even times, have moved a market in favor of the Uranium market.

About The Emerging Markets Report:
The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

For more informative reports such as this, please sign up at https://emergingmarketsconsulting.com/

Must Read OTC Markets/SEC policy on stock promotion and investor protection

  • https://www.otcmarkets.com/learn/policy-on-stock-promotion
  • https://www.otcmarkets.com/learn/investor-protection
  • https://www.sec.gov/news/press-release/2017-79
  • https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.

EMC is under contract to receive $100,000 by Laramide Resources Ltd. (LMRXF) for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. https://emergingmarketsconsulting.com/disclaimer/

Emerging Markets Consulting, LLC
Florida Office
390 North Orange Ave STE 2300
Orlando, FL 32801
E-mail: jamespainter@emergingmarketsllc.com
Web: https://emergingmarketsconsulting.com/

Image: https://www.globenewswire.com/newsroom/ti?nf=ODU1OTIzOSM0OTQ1MzUzIzUwMDEwNDk4OA==
Image: https://ml.globenewswire.com/media/N2I0MzE0YzgtYzViOS00YjNjLWFkZWMtYmRkMDM1NzE3YjVhLTUwMDEwNDk4OA==/tiny/Laramide-Resources-Ltd-and-Eme.png

Image: Primary Logo

Source: Laramide Resources Ltd. (LMRXF) and Emerging Markets Consulting, LLC.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.